Mistry described Scp776 as a “designer drug.” She explained that IGF-1 receptors are abundant throughout the body, and IGF-1 ...

People with thyroid eye disease receiving infusions of the insulin-like growth factor-1 receptor veligrotug report improved quality of life after 15 weeks of treatment.

Viridian seeks Priority Review for veligrotug, aiming for a potential mid-2026 commercial launch if approved. Global phase 3 ...

(Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today announced that the company will host a virtual ...

(Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today reported financial results and provided a business ...

A British study examined whether pomegranate polyphenols can influence a hormone closely linked to muscles and regeneration ...

Crinetics Pharmaceuticals' stock has surged after FDA approval of Palsonify for acromegaly. Click here to read the latest ...

For years, protein shakes have been hailed as the magic potion for muscle gain and recovery. Every gym-goer in India seems to ...

Peptides have become an increasingly important area of research in numerous scientific fields, especially for their diverse functions.

A once-daily oral quadruple receptor agonist induced up to 13.8% weight loss at 13 weeks among adults with overweight or ...

Prediabetes burden is rising globally and in India. The latest IDF 2025 Atlas estimated that in 2024, 634.8 million adults (12%) worldwide had IGT, including 89.9 million in India, projected ...

Learn more about whether Protagonist Therapeutics, Inc. or Viridian Therapeutics, Inc. is a better investment based on AAII's ...